Holen Sie sich die Stockscreener-App
5.82
3.56%
0.20
Handel nachbörslich:
5.81
-0.01
-0.17%
Finanzdaten der Akari Therapeutics Plc Adr-Aktie (AKTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Selling, General, and Administrative
|
1.975
|
- | - | 3.048 | 1.709 |
| Interest Income/Expense |
0.10
|
- | - | - | - |
| Operating Income/Loss |
-7.404
|
- | -3.525 | -5.278 | -2.927 |
| Nonoperating Income/Loss |
-0.084
|
- | -0.18 | 1.506 | 0.032 |
| Income/Loss From Continuing Operations Before Tax |
295.15%
-7.488
|
-1.895 | -3.705 | -3.772 | -2.895 |
| Income/Loss From Continuing Operations After Tax |
295.15%
-7.488
|
-1.895 | -3.705 | -3.772 | -2.895 |
|
Net Income/Loss
|
237.73%
-6.40
|
-1.895 | -3.705 | -3.772 | -2.895 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
65,326.24
|
- | 54,588.28 | 4,976.08 | 24,386.01 |
| Diluted Average Shares |
65,326.24
|
- | 54,588.28 | 4,976.08 | 24,386.01 |
| Basic Earnings Per Share |
-
|
- | - | - | - |
| Diluted Earnings Per Share |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.77%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):